These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1055 related articles for article (PubMed ID: 221544)

  • 1. Human intestinal lipoproteins. Studies in chyluric subjects.
    Green PH; Glickman RM; Saudek CD; Blum CB; Tall AR
    J Clin Invest; 1979 Jul; 64(1):233-42. PubMed ID: 221544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human apolipoprotein A-IV. Intestinal origin and distribution in plasma.
    Green PH; Glickman RM; Riley JW; Quinet E
    J Clin Invest; 1980 Apr; 65(4):911-9. PubMed ID: 6987270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic fate of chylomicron phospholipids and apoproteins in the rat.
    Tall AR; Green PH; Glickman RM; Riley JW
    J Clin Invest; 1979 Oct; 64(4):977-89. PubMed ID: 225354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoprotein composition and turnover in rat intestinal lymph during steady-state triglyceride absorption.
    Holt PR; Wu AL; Clark SB
    J Lipid Res; 1979 May; 20(4):494-502. PubMed ID: 222857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph chylomicron formation during the inhibition of protein synthesis. Studies of chylomicron apoproteins.
    Glickman RM; Kirsch K
    J Clin Invest; 1973 Nov; 52(11):2910-20. PubMed ID: 4356002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipoproteins and apolipoproteins in rats with streptozotocin-induced diabetes.
    Bar-On H; Roheim PS; Eder HA
    J Clin Invest; 1976 Mar; 57(3):714-21. PubMed ID: 175093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
    Attman PO; Alaupovic P; Tavella M; Knight-Gibson C
    Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoprotein A-I synthesis in normal intestinal mucosa and in Tangier disease.
    Glickman RM; Green PH; Lees RS; Tall A
    N Engl J Med; 1978 Dec; 299(26):1424-7. PubMed ID: 213720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism.
    Shepherd J; Packard CJ; Patsch JR; Gotto AM; Taunton OD
    J Clin Invest; 1979 May; 63(5):858-67. PubMed ID: 221531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal apoproteins during fat absorption.
    Schonfeld G; Bell E; Alpers DH
    J Clin Invest; 1978 Jun; 61(6):1539-50. PubMed ID: 350901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic secretion of lipoproteins in the rat and the effect of experimental nephrosis.
    Marsh JB; Sparks CE
    J Clin Invest; 1979 Nov; 64(5):1229-37. PubMed ID: 227928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay of total plasma apolipoprotein B concentration in human subjects.
    Schonfeld G; Lees RS; George PK; Pfleger B
    J Clin Invest; 1974 May; 53(5):1458-67. PubMed ID: 4363408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.
    Baggio G; Manzato E; Gabelli C; Fellin R; Martini S; Enzi GB; Verlato F; Baiocchi MR; Sprecher DL; Kashyap ML
    J Clin Invest; 1986 Feb; 77(2):520-7. PubMed ID: 3944267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of apoprotein synthesis and secretion in the human hepatoma Hep G2. The effect of exogenous lipoprotein.
    Craig WY; Nutik R; Cooper AD
    J Biol Chem; 1988 Sep; 263(27):13880-90. PubMed ID: 2843542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in levels and interrelations of plasma apolipoproteins induced by diet.
    Schonfeld G; Weidman SW; Witztum JL; Bowen RM
    Metabolism; 1976 Mar; 25(3):261-75. PubMed ID: 175240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a lipoprotein profile using capillary electrophoresis and mass spectrometry.
    Macfarlane RD; Bondarenko PV; Cockrill SL; Cruzado ID; Koss W; McNeal CJ; Spiekerman AM; Watkins LK
    Electrophoresis; 1997 Sep; 18(10):1796-806. PubMed ID: 9372272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV.
    Goldberg IJ; Scheraldi CA; Yacoub LK; Saxena U; Bisgaier CL
    J Biol Chem; 1990 Mar; 265(8):4266-72. PubMed ID: 2307668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.